Please login to the form below

Not currently logged in

Emerging Companies

This page shows the latest Emerging Companies news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

Beigene is part of a wave of new China-based biotech companies who are emerging rapidly thanks to new rules in Hong Kong’s stock market, HKEX. ... A total of eight companies in biotech research have filed since May, and now Beigene is planning the

Latest news

  • Smart solutions Smart solutions

    As pharmaceutical manufacturers face the threats of generic competition and increasing payer pressure, technology-enabled solutions are emerging as a smart way for companies to add genuine value and extend the ... also feeling the heat and companies are

  • Fair to medalling Fair to medalling

    There needs to be a greater focus on emerging environments and better contingency planning. ... However, many plans don't adequately account for emerging risks. Companies need mechanisms in place to monitor and respond to external drivers so they can

  • Astellas launches digital health investment company Astellas launches digital health investment company

    DigiTx Partners aims to identify and foster those companies that will meaningfully contribute to this improvement. ... With digital health of increasing interest to pharma a number of companies have set up 'accelerator' programmes to support emerging

  • Prices of AZ and GSK drugs slashed in China Prices of AZ and GSK drugs slashed in China

    The price reductions are a blow to companies hoping to expand in emerging markets such as China, with prospects already dented by the downturn in the global economy, pricing pressure on ... Both GSK and AZ have previously suggested that emerging markets

  • Pfizer signs $900m-plus deal with WAVE for metabolic R&D Pfizer signs $900m-plus deal with WAVE for metabolic R&D

    Commenting on the deal, Morris Birnbaum, chief scientific officer at Pfizer's cardiovascular and metabolic research unit, said: "By working together to develop unique proprietary technologies emerging from both companies, we

More from news
Approximately 0 fully matching, plus 48 partially matching documents found.

Latest Intelligence

  • Nudge-nudge, think-think Nudge-nudge, think-think

    A common UX feature is goal- setting, but companies must dig deeper than bolting long-term treatment goals onto their programmes. ... There are, says Maria, good examples of more holistic and action-oriented interventions emerging from big pharma

  • Dispensing with the past Dispensing with the past

    Current board composition at the top pharma companies shows that on average 22% of board directors have some operational experience in emerging markets. ... Just under half (40%) of top pharma companies have three or more board directors with operational

  • Healthcare costs Healthcare costs

    The healthcare industry is being disrupted - new business models and strategies are emerging and companies are stepping up to take their place in the new landscape.”. ... For pharmaceutical companies, the ability to develop more effective drugs through

  • Adapting to the digital consumer Adapting to the digital consumer

    Based on the expected outcome, companies need to decide where to be present and build the required capabilities. ... There are also new types of businesses emerging. Companies such as LifeQ, which uses computational systems biology to provide consumers

  • Choosing wisely Choosing wisely

    How to make the best of emerging markets. The notion that pharmaceutical companies are pondering which emerging markets they should target is slightly disingenuous. ... The whole concept of emerging markets is dubious,” says Mark Chataway, Principal

More from intelligence
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Aromatherapy Market : Quantitative Market Analysis, Current and Future Trends, 2016-2026

    Need more information about Report methodology? @ . Considering the growth prospects in emerging markets, various established companies and startup firms have entered aromatherapy market to capture maximum share in emerging markets, as ... Companies

  • Training the next generation of biotech leaders

    This skills shortage is a major challenge for the sector. Currently, the number of biotech companies emerging is growing much faster than the talent pool. ... society. “We look at the manufacturing challenges we are facing for emerging healthcare

  • Connected Health

    In recent decades, emerging technologies have repeatedly forced smart companies to answer the question: what’s new here and what’s our strategy now? ... Today, smart pharma companies should be asking that same question about another major development:

  • Addison Whitney Health

    Our work with established and emerging companies has created hundreds of strong, long-lasting brands.

  • Competition from within

    Published in eyeforpharma July 29 by Rachel Howard. To what extent can Big Pharma expect to face an increasing challenge from globalizing pharmaceutical companies based in emerging markets? ... In ten years’ time, will more ‘home-grown’ emerging

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch